/Investor DB

North South Ventures — Full Portfolio

32 tracked investments · listed companies and verified rows first

Adentrisadentris.comin𝕏Seed

Adentris builds AI agents that automate healthcare revenue cycle management, specifically addressing unpaid claims and billing denials for mid-market healthcare providers.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSSan Francisco, US

Dmitry Karpov(Founder)inAlex Odin(Founder / CTO)inSergey Yudovskiy(Founder / CPO)inYudovskiyinOdin AlexinGerald Maccioli(Chief Medical Officer)in

Co-investorsFjor FoundersY CombinatorDavidovs Venture CollectiveDVCLiquid VenturesRed Bike Capital+1 more

Andromeda Surgicalandromedasurgical.comin𝕏

Andromeda Surgical develops an AI-guided surgical platform that provides GPS-like navigation and autonomous task capabilities to surgeons, starting with endourology procedures.

AI & Machine LearningHealthtechMedical DevicesRoboticsSan Francisco, US

Nick Damiano(Founder)inKartik Tiwari(Founder)in

Co-investorsEarl Grey CapitalNZVCPhaze VenturesRebel FundRoar VenturesStandard Capital+23 more

Auricleauricle.comin𝕏Seed · May 2021

Auricle develops a neurostimulation implant designed to restore hearing for patients who do not benefit from hearing aids or existing solutions.

Deep TechHealthtechMedical DevicesSan Francisco, US

Francis Wong(Founder)inJay Dhuldhoya(Founder)inJonathan T. Pearson(Executive Officer, Director)

Co-investorsY CombinatorStartXAgrolimen VenturesFAST — by GETTYLAB

Bristlebristlehealth.comin𝕏Seed

Bristle provides digital tools and insights to help people assess and improve their oral health, positioning dental care as a preventive step toward overall wellness.

Digital HealthHealthtechWellness & FitnessSan Francisco, US

David Lin(Founder)inBrian Maurer(Founder)inShivam Patel(Founder)in

Co-investorsInitialized CapitalR/GA VenturesY Combinator645 VenturesAxial VCBR Capital

Commons Cliniccommonsclinic.com

Commons Clinic is an orthopedic care provider offering treatment for spine, joint, and sports medicine conditions, along with preventive health services such as full-body MRI and biomarker labs.

Digital HealthHealthtechWellness & FitnessAustin, US

Brad Hively(Director)inNick Aubin(Founder)inPaulo Marques Da Costa(Executive Officer, Director)Prithviraj Singha Roy(Director)in

BoardJohn Loser(Director)inDavid Berry(Director)in

Co-investorsCourtside VenturesFloating PointSteelSky VenturesTime BioVenturesAverin CapitalRA Capital+1 more

Delfino AIdelfino.aiinSeed

Delfino provides an AI-powered platform that automates calls to insurance payors to retrieve eligibility verification, prior authorization checks, and claim status information for healthcare providers and patients.

AI & Machine LearningEnterprise SoftwareHealthtechSan Francisco, US

Sneh Patel(Founder)inKimberly McManus(Founder)in

Co-investorsY Combinator

Feanix Biotechnologiesfeanixbio.comin

Feanix Autopilot is an AI-powered platform that combines whole-genome sequencing, farm performance data, and economics to provide herd-level breeding and culling recommendations for dairy farmers.

Advanced ManufacturingAgTechAI & Machine LearningAsheville, US

Mitchell Angove(Founder)inTom Bishop(Founder)in

Co-investorsInitialized CapitalOverwater Ventures LlcY CombinatorAndreessen HorowitzCollaborative FundGeneral Catalyst

FlowDeployflowdeploy.comin𝕏SeedDefunct

FlowDeploy provides a platform for bioinformaticians to build, execute, and share data analysis pipelines in the cloud using tools like Nextflow or Snakemake, with features including cloud cost controls, credential management, and a web interface for pipeline monitoring.

Data & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US

Noah Lebovic(Founder)inBryce Cai(Founder)in

Co-investorsY Combinator10X CapitalDecacorn CapitalFAST — by GETTYLABMesia VenturesOriginal Capital+3 more

Granza Biogranzabio.comin𝕏Feb 2024

Granza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.

BiotechDeep TechDigital HealthHealthtechSan Francisco, US

Prof. Dustin(Co-founder)Ashwin Nandakumar(Founder)inAshwin Jainarayanan(Founder)inAshwin Menon Nandakumar(Founder)in

Co-investorsFelicis VenturesMetaplanetOxonian VenturesRitual CapitalY CombinatorOxford Angel Fund+4 more

Hey Reviaheyrevia.aiin𝕏Seedacquired by OpenLoop

OpenLoop is a white-label telehealth platform that enables healthcare brands to launch and scale virtual care services.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSSan Francisco, US

Shaun Wei(CEO & Co-founder)inDavid (Wenbo) Zhu(Founder)in

Co-investorsY CombinatorAmino CapitalLlama venturesTwenty Two Ventures

Hormone-Free IVFvitra.bioin

Vitra Bio is a biotechnology company developing technology aimed at transforming fertility treatment.

BiotechFemTechHealthtech

Ivana Muncie-Vasic(Chief Executive Officer and Founder)inJohn Langowski(Chief Technology Officer)in

Co-investorsBreakout VenturesForeground CapitalSpacecadet VenturesBoom Capital VenturesRefactor Capital

Kiwi Biosciencesfodzyme.comin𝕏Seed

FODZYME develops an enzyme powder supplement that breaks down FODMAPs in food, particularly fructans found in garlic, onions, and wheat, for people with digestive sensitivities.

BiotechConsumerFoodTechHealthtechWellness & FitnessBoston, US

Anjie Liu(Founder)inDavid Hachuel Gurska(Founder)in

Co-investorsY CombinatorAcacia Venture Capital PartnersAxial VCFAST — by GETTYLABHarvard Management CompanyHENRY Collective Ventures+1 more

Kopra Biokopra.bioinSeed

Kopra Bio develops cancer immunotherapy technology that converts cancer cells into biofactories to produce their own destruction.

BiotechHealthtechMedical DevicesSan Francisco, US

Alexander Haddad(Founder)in

Co-investorsBoutique Venture PartnersChamaeleonLexi VenturesMetaplanetMythos Ventures Management, LlcTranspose Platform Management+10 more

Ligo Biosciencesligo.bioin𝕏Seed

Ligo develops computational tools for enzyme design by combining large language models with specialized neural networks to enable scientists and AI agents to discover new enzymes and biological functions.

AI & Machine LearningBiotechClimate TechDeep TechHealthtechSan Francisco, US

Edward Harris(Founder)inEmily Egerton-Warburton(Founder)inArda Goreci(Founder)in

Co-investorsA.Capital VenturesHAWKTAILOxonian VenturesTranspose Platform ManagementWayfinder VenturesY Combinator+14 more

Lucislucis.lifein𝕏

Lucis provides personalized health monitoring and guidance by combining laboratory biomarker testing with educational insights and actionable recommendations.

AI & Machine LearningDigital HealthHealthtechWellness & FitnessParis, FR

Max Berthelot(Founder)inBaptiste Debever(Co-founder / CTO)inJulien Do Vale(M.D., MSc, Chief Medical Officer)in

BoardAntoine Andremont(M.D., PHD, President of the scientific board)Jérémy Bos(MD, MSc, Specialist in public health and clinical epidemiology)

Co-investorsCircle & Co.CloverMotier VenturesY Combinator199 VenturesGeneral Catalyst+3 more

Maiaourmaia.comin𝕏Seed

Maia is an AI-powered platform that provides relationship support and communication guidance for couples, offering advice, conflict resolution tools, and interactive features like conversation starters and date planning.

AI & Machine LearningConsumerHealthtechMental HealthWellness & FitnessSan Francisco, US

Claire Wiley(Founder)in

Co-investorsY CombinatorAgrolimen VenturesGoodwater Capital

Miraclemiracleml.cominSeed

Miracle unifies data from multiple clinical trial platforms to provide automated insights for healthcare professionals in biopharma.

AI & Machine LearningBiotechEnterprise SoftwareHealthtechSaaSSan Francisco, US

Jin Kim(Founder)in

Co-investorsBusiness Growth FundY Combinator10X CapitalSoma CapitalThe E14 FundValon Capital

Noetiknoetik.aiin𝕏Sep 2023 · $14M

Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets.

AI & Machine LearningBiotechHealthtechSouth San Francisco, US

Jacob Rinaldi(Executive Officer, Director, Promoter)inRonald Alfa(Executive Officer, Director, Promoter)Ron Alfa, MD, PhD(Co-Founder, CEO)in

BoardJames Hardiman(Director)inAmy Schulman(Director)

Co-investors11.2 CapitalBreakout LabsBreakout VenturesCatalio Capital Management, LPEPIC VENTURESLinearis Ventures+5 more

ParcelBioparcelbio.cominFeb 2026

ParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies.

AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US

David Weinberg(Founder)inChris Carlson(Founder)in

BoardMorgan Cheatham(Director)in

Co-investorsY CombinatorBreyer CapitalGeneral CatalystLexi VenturesMetaplanetRitual Capital+9 more

Persephone Biosciencespersephone.bioinSeed · Feb 2021

Persephone develops a synbiotic supplement for infants that combines probiotics (keystone Bifidobacterium strains) with prebiotics found in human breast milk to replenish gut bacteria linked to digestion, immunity, and development.

BiotechConsumerDigital HealthFemTechHealthtechSan Diego, US

Stephen Van Dien(Founder/CTO)inStephanie Culler(CEO & Co-Founder)in

Co-investorsFirst Bight VenturesPropel Bio PartnersBioBritFifty YearsHemi Ventures, LlcOcampo Capital+11 more

ResistanceBioresistance.bioinSeed · Jan 2024Defunct

ResistanceBio develops treatments to address drug resistance in cancer patients.

BiotechHealthtechSan Francisco, US

Nicholas Goldner(CEO/Founder)inChristopher Bulow(Founder)inKYLE LAPHAM(Executive Officer, Director)

BoardOMRI AMIRAV-DRORY(Director)in

Co-investorsFifty YearsY CombinatorAlumni VenturesAsymmetry VenturesBrightstone Venture CapitalCantos Ventures+10 more

Rinserinse.dentalin𝕏Seed

Rinse combines technology and hospitality with science-based dental care to provide preventive oral health services through modern studio experiences.

ConsumerDigital HealthHealthtechWellness & FitnessSan Francisco, US

Casey Harlin(Founder)in

Co-investorsArena VenturesOptum VenturesPJCY CombinatorAccelerator VenturesAsymmetry Ventures+5 more

Samos Insurancesamos.insurein𝕏Seed

Samos provides life insurance products tailored for individuals undergoing scheduled surgical procedures, with rapid approval processes and no medical examinations required.

FintechInsurTechKitchener, CA

Leon Punambolam(Founder)in

Co-investorsMS&AD VenturesY CombinatorAlicorn Venture PartnersLiquid VenturesMGV.VCPioneer+1 more

SFA Therapeuticssfatherapeutics.comin𝕏

SFA Therapeutics develops oral therapeutic candidates based on deuterated short-chain fatty acids to treat autoimmune and oncologic diseases.

BiotechHealthtechPhiladelphia, US

Ira Spector(Founder)inAlla Arzumanyan(Founder)inMark Feitelson(Founder)in

Co-investorsAcequia Capital (AceCap)Farvatn VentureImmeasurableY CombinatorAsymmetry VenturesBen Franklin Technology Partners+4 more

Slingshotslingshotml.cominSeedAcquired

An AI system that reviews medical records to verify whether diagnoses are substantiated by available clinical evidence, helping patients reduce billing errors and associated costs.

HealthtechSan Francisco, US

Zoe Holderness(Founder)in

Co-investorsY CombinatorAndreessen HorowitzPioneer

Syrona Healthsyronahealth.comin𝕏Seed

Syrona Health provides virtual healthcare support for employees across different life stages, addressing health transitions and personal challenges.

Digital HealthHealthtechHR TechLondon, GB

Anya Roy(Founder)in

Co-investorsY CombinatorCoho DeeptechPeterson Venture PartnersVenture Investment Associates

Talus Biotalus.bioin𝕏Seed · Jul 2024

Talus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts.

AI & Machine LearningBiotechDeep TechHealthtechSeattle, US

Alex Federation(Founder)inLindsay Pino(Founder)inAlex Federation, Ph.D.(Chief Executive Officer & Co-Founder)Lindsay Pino, Ph.D.(Chief Technology Officer & Co-Founder)

BoardOmri Amirav-Drory(Director)inJ. Seth Strattan(Director)in

Co-investorsFarvatn VentureFifty YearsFundersClubJude GomilaNFXTwo Bear Capital+9 more

Thumbnail for SyntheXsynthexlabs.comin𝕏

SyntheX develops the ToRFLEx platform, a first-in-class drug discovery technology that enables screening for compounds that modulate protein-protein interactions and targeted protein degradation for previously inaccessible drug targets identified by geneticists.

AI & Machine LearningBiotechDeep Tech

Maria Soloveychik(PhD)in

Co-investorsOMX VenturesThe Column Group8VC

Tiny Healthtinyhealth.cominAug 2024

Tiny Health offers at-home gut and vaginal microbiome test kits with age-specific, evidence-based reports that recommend diet, supplement, and lifestyle changes.

Digital HealthHealthtechWellness & Fitness

Cheryl Sew Hoy(Founder)in

Co-investorsAlumni VenturesB Capital GroupB4 CapitalCartan CapitalModi VenturesNext Coast Ventures+11 more

Vinemedvinemed.com

Vine Medical develops soft robotic medical devices designed to enhance clinician safety and outcomes during procedures.

HealthtechMedical DevicesRoboticsSanta Barbara, US

David Haggerty, PhD(Co-Founder & Chief Executive Officer)Elliot W. Hawkes, PhD(Co-Founder & Chief Technology Officer)David Drover, MD, FRCP(C)(Co-Founder & Chief Medical Officer)

YourChoiceyourchoicetx.com

YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials.

BiotechFemTechHealthtech

Akash Bakshi, MSc(Co-founder & CEO)Nadja Mannowetz, PhD(Co-founder & CSO)

Co-investorsBlue Bear VenturesCivilization Ventures Management, LlcForeground CapitalFuture VenturesPortfoliaOlive Tree Capital+1 more

YourChoice Therapeuticsychoicetx.cominJul 2022

YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production.

BiotechHealthtechMedical DevicesSan Francisco, US

Akash Bakshi(Founder)inNadja Mannowetz(Founder)in

Co-investorsBlue Bear VenturesForeground CapitalOlive Tree CapitalPortfoliaY Combinator8VC+8 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.